These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30890061)

  • 1. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.
    Hoffman RM; Angelidou KN; Brummel SS; Saidi F; Violari A; Dula D; Mave V; Fairlie L; Theron G; Kamateeka M; Chipato T; Chi BH; Stranix-Chibanda L; Nematadzira T; Moodley D; Bhattacharya D; Gupta A; Coletti A; McIntyre JA; Klingman KL; Chakhtoura N; Shapiro DE; Fowler MG; Currier JS;
    HIV Clin Trials; 2018 Dec; 19(6):209-224. PubMed ID: 30890061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.
    Currier JS; Britto P; Hoffman RM; Brummel S; Masheto G; Joao E; Santos B; Aurpibul L; Losso M; Pierre MF; Weinberg A; Gnanashanmugam D; Chakhtoura N; Klingman K; Browning R; Coletti A; Mofenson L; Shapiro D; Pilotto J;
    PLoS One; 2017; 12(5):e0176009. PubMed ID: 28489856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.
    Watts DH; Brown ER; Maldonado Y; Herron C; Chipato T; Reddy L; Moodley D; Nakabiito C; Manji K; Fawzi W; George K; Richardson P; Zwerski S; Coovadia H; Fowler M;
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):299-306. PubMed ID: 23846568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.
    Flynn PM; Taha TE; Cababasay M; Fowler MG; Mofenson LM; Owor M; Fiscus S; Stranix-Chibanda L; Coutsoudis A; Gnanashanmugam D; Chakhtoura N; McCarthy K; Mukuzunga C; Makanani B; Moodley D; Nematadzira T; Kusakara B; Patil S; Vhembo T; Bobat R; Mmbaga BT; Masenya M; Nyati M; Theron G; Mulenga H; Butler K; Shapiro DE;
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):383-392. PubMed ID: 29239901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial.
    Atuhaire P; S Brummel S; Mmbaga BT; Angelidou K; Fairlie L; Violari A; Theron G; Mukuzunga C; Mawlana S; Mubiana-Mbewe M; Naidoo M; Makanani B; Mandima P; Nematadzira T; Suryavanshi N; Mbengeranwa T; Loftis A; Basar M; McCarthy K; Currier JS; Fowler MG;
    PLoS One; 2020; 15(1):e0228003. PubMed ID: 31999753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.
    Melekhin VV; Shepherd BE; Jenkins CA; Stinnette SE; Rebeiro PF; Bebawy SS; Rasbach DA; Hulgan T; Sterling TR
    AIDS Patient Care STDS; 2010 May; 24(5):279-86. PubMed ID: 20438375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding.
    Brummel SS; Taha TE; Angelidou KN; Saidi F; Atuhaire P; Dula D; Moodley D; Matubu A; Chareka G; Nevrekar N; Vhembo T; Fairlie L; Theron G; Mlay P; George K; Basar M; Chakhtoura N; Browning R; Fowler MG; Currier JS;
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):450-454. PubMed ID: 33273210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
    Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
    Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery.
    Giuliano M; Andreotti M; Liotta G; Jere H; Sagno JB; Maulidi M; Mancinelli S; Buonomo E; Scarcella P; Pirillo MF; Amici R; Ceffa S; Vella S; Palombi L; Marazzi MC
    PLoS One; 2013; 8(7):e68950. PubMed ID: 23894379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component.
    Flynn PM; Taha TE; Cababasay M; Butler K; Fowler MG; Mofenson LM; Owor M; Fiscus S; Stranix-Chibanda L; Coutsoudis A; Gnanashanmugam D; Chakhtoura N; McCarthy K; Frenkel L; Beck I; Mukuzunga C; Makanani B; Moodley D; Nematadzira T; Kusakara B; Patil S; Vhembo T; Bobat R; Mmbaga BT; Masenya M; Nyati M; Theron G; Mulenga H; Shapiro DE;
    J Acquir Immune Defic Syndr; 2021 Oct; 88(2):206-213. PubMed ID: 34108383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
    Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women.
    Cohan D; Natureeba P; Koss CA; Plenty A; Luwedde F; Mwesigwa J; Ades V; Charlebois ED; Gandhi M; Clark TD; Nzarubara B; Achan J; Ruel T; Kamya MR; Havlir DV
    AIDS; 2015 Jan; 29(2):183-91. PubMed ID: 25426808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.
    Kilewo C; Karlsson K; Ngarina M; Massawe A; Lyamuya E; Swai A; Lipyoga R; Mhalu F; Biberfeld G;
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):406-16. PubMed ID: 19730269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
    Stranix-Chibanda L; Tierney C; Sebikari D; Aizire J; Dadabhai S; Zanga A; Mukwasi-Kahari C; Vhembo T; Violari A; Theron G; Moodley D; George K; Fan B; Sommer MJ; Browning R; Mofenson LM; Shepherd J; Nelson B; Fowler MG; Siberry GK;
    PLoS One; 2021; 16(2):e0246272. PubMed ID: 33544759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
    Kesho Bora Study Group
    Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
    Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
    Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    Onoya D; Sineke T; Brennan AT; Long L; Fox MP
    AIDS; 2017 Jul; 31(11):1593-1602. PubMed ID: 28463877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.